DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr | ₹1,413 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹2,156 Cr |
Mar2023 | ₹1,793 Cr |
Mar2022 | ₹2,424 Cr |
Mar2021 | ₹1,677 Cr |
Mar2020 | ₹1,413 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹2,156 Cr | 20.25 | |
Mar2023 | ₹1,793 Cr | -26.03 | |
Mar2022 | ₹2,424 Cr | 44.58 | |
Mar2021 | ₹1,677 Cr | 18.62 | |
Mar2020 | ₹1,413 Cr | - |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹149,272.1 Cr | 4.1% | -7% | 52% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
MANKIND PHARMA | ₹102,348.0 Cr | 0.9% | -15.6% | 21.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 4.1% |
-7% |
52% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses